Myrrh is one of the oldest and most esteemed Etheric resins aside from the Boswellia tree resin. It is harvested from the spiked bush of Commiphora Myrrha, which grows in the driest desert areas of northeastern Africa and the Arabian Peninsula. Myrrh Resin is the second consecrated gift to Jesus and, together with Boswellia, marked the transition of the Age of Aries into the Age of Pisces more than 2000 years ago. In the old world, it had the same or even higher value than gold. Until this day, together with Boswellia, it is used in the most crucial temple rituals of almost all religions and spiritual beliefs in the world.
​
Myrrh or "Murr" derives from the Semitic languages and means bitter. The Egyptians highly appreciated it; they were using her as indispensable temple incense, anointing oil, an antiseptic for the mouth and cut wounds, for the treatment of arthritis, and with natron as the main ingredient for the embalming of mummies. This mystical shrub is often mentioned in the Old and New Testaments. Its Etheric Resin was the central incense and anointing oil in the first and the second Jerusalem temple. It is written in the Encyclopedia of Islamic Herbal Medicine in Koran: "Fumigate your houses with the scent of Boswellia, Mira, and Sa'tar."
In traditional Chinese medicine, it is said to have exceptional efficacy on the heart, liver, and spleen meridians, as well as "blood-moving" powers to purge stagnant blood from the uterus. It is therefore recommended for the treatment of rheumatic, arthritic, and circulatory problems and the treatment of amenorrhea, dysmenorrhea, menopause, and uterine tumors.
In pharmacy, Myrrh is used as a potent antiseptic in high-quality oral water and toothpaste. It is also used for disinfection of cut wounds, wound healing, healing of some skin diseases, as an analgesic for toothaches, and can be used in liniment for bruises, aches, and sprains.
In medicine, it is used to treat gastrointestinal disorders, ulceration, colds, cough, asthma, lung congestion, arthritis, and cancer. As part of more extensive research for anticancer compounds from plants, the researchers obtained extracts from a Commiphora Myrrha. They tested it against a human breast tumor cell line (MCF-7) known to be resistant to anticancer drugs. Research data indicated that the extract killed all of the cancer cells.
